📰 Device Exemption News
Page 4 - Device Exemption News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Device Exemption. Real-time updates on events, politics, business and more.
March 6, 2023
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its PulseSelect™ Pulsed Field Ablation (PFA) System...
February 23, 2023
22.02.2023 - REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) - Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the Company), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and ...
January 19, 2023
This article looks at Investigational Device Exemptions (IDE) and their use in clinical studies.
January 11, 2023
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval - read this article along with other careers information, tips and advice on BioSpace
January 11, 2023
Get latest articles and stories on Business at LatestLY. SELUTION SLR™, MedAlliances novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions. Business News | MedAlliance SELUTION SLR is the First DEB to Receive Coronary De Novo IDE Approval, Its Fourth FDA IDE DEB Approval.
November 28, 2022
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 28, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced an update on the COSIRA-II
November 15, 2022
Latin America is a compelling region to conduct medtech early feasibility studies due to its ethnically diverse population, its high rate of...
November 9, 2022
Recently, the U.S. Food and Drug Administration (FDA) released two proposed rules that aim to clarify inconsistencies between FDA’s human subject protection regulations and the Federal...
October 25, 2022
/PRNewswire/ -- Following our communication last week "MedAlliance to be acquired by Cordis", MedAlliance is pleased to make the following announcement:...
October 25, 2022
GENEVA, Oct. 25, 2022 /PRNewswire/ -- Following our communication last week "MedAlliance to be acquired by Cordis", MedAlliance is pleased to make the following announcement: SELUTION